Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Cragg

Showing results (11-20 of 178) with videos related to

Pageof 18
Sort By:
Oncoimmunology|April 9, 2016
Resistance is futile: Targeting the inhibitory FcγRIIB (CD32B) to maximize immunotherapyAli Roghanian, Mark S Cragg, Björn Frendéus
Nature Immunology|July 12, 2023
Publisher Correction: Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Nature Immunology|July 6, 2023
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Nature Immunology|August 23, 2023
Publisher Correction: Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Frontiers in Immunology|May 14, 2023
Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectivesOsman Dadas, Ayse Ertay, Mark S Cragg
Seminars in Immunology|December 19, 2024
The complement system in clinical oncology: Applications, limitations and challengesDaniel Ajona, Mark S Cragg, Ruben Pio
Frontiers in Immunology|July 14, 2020
Editorial: Roles of Fc Receptors in Disease and TherapyLatha P Ganesan, Mark S Cragg, Gestur Vidarsson
The International Journal of Biochemistry & Cell Biology|December 15, 2010
B cells--masters of the immunoverseAndrew T Vaughan, Ali Roghanian, Mark S Cragg
Cancers|October 13, 2021
Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody ImmunotherapiesKhiyam Hussain, Mark S Cragg, Stephen A Beers
Pharmacological Research|July 19, 2015
Antibody modulation: Limiting the efficacy of therapeutic antibodiesAndrew T Vaughan, Mark S Cragg, Stephen A Beers
Pageof 18

Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Oncoimmunology|April 9, 2016
Resistance is futile: Targeting the inhibitory FcγRIIB (CD32B) to maximize immunotherapyAli Roghanian, Mark S Cragg, Björn Frendéus
Nature Immunology|July 12, 2023
Publisher Correction: Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Nature Immunology|July 6, 2023
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Nature Immunology|August 23, 2023
Publisher Correction: Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapyFalk Nimmerjahn, Gestur Vidarsson, Mark S Cragg
Frontiers in Immunology|May 14, 2023
Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectivesOsman Dadas, Ayse Ertay, Mark S Cragg
Seminars in Immunology|December 19, 2024
The complement system in clinical oncology: Applications, limitations and challengesDaniel Ajona, Mark S Cragg, Ruben Pio
Frontiers in Immunology|July 14, 2020
Editorial: Roles of Fc Receptors in Disease and TherapyLatha P Ganesan, Mark S Cragg, Gestur Vidarsson
The International Journal of Biochemistry & Cell Biology|December 15, 2010
B cells--masters of the immunoverseAndrew T Vaughan, Ali Roghanian, Mark S Cragg
Cancers|October 13, 2021
Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody ImmunotherapiesKhiyam Hussain, Mark S Cragg, Stephen A Beers
Pharmacological Research|July 19, 2015
Antibody modulation: Limiting the efficacy of therapeutic antibodiesAndrew T Vaughan, Mark S Cragg, Stephen A Beers
Pageof 18